Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Quality of life and employment in persons with multiple sclerosis.
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.
Fingolimod and multiple sclerosis: Four cautionary tales.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
A questionnaire survey comparing the educational priorities of patients and medical students in the management of multiple sclerosis.
Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab.
TREM2 regulates microglial cell activation in response to demyelination in vivo.
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments.
Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis.
Carbon Monoxide and the Brain : Time to Rethink the Dogma.
[Pharmaceutical prescription for multiple sclerosis : Evaluation of pharmaceutical consumption at private health insurance.]
[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.
Statins and Neuroprotection: Basic Pharmacology Needed.
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience.
Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis.
CD4+ T cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.
Health related quality of life in patients recently diagnosed with multiple sclerosis.
Errata Corrige: The Neuroradiology Journal 25: 17-21, 2012. Multiple Sclerosis Lesions in the Brain: Computer-Assisted Assessment of Lesion Load Dynamics on 3D FLAIR MR Images.
Acute paraplegia caused by Schistosoma mansoni.
Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice.
Comparison of the Effect of 8 weeks Aerobic and Yoga Training on Ambulatory Function, Fatigue and Mood Status in MS Patients.
Pages
« first
‹ previous
…
352
353
354
355
356
357
358
359
360
…
next ›
last »